DPP-4 INHIBITORS AND GLP-1RAS: CARDIOVASCULAR SAFETY AND BENEFITS

Descargar Publicación
The combined role of obesity and depressive symptoms in the association with ischaemic heart disease and its subtypes Treatment of Type 2 Diabetes: The American Association of Clinical Endocrinologists Meeting, May 2002